| 25AMIP101A Antimicrobial Stewardship and Infection Prevention and Control-Basic CourseP/F |
| Topic |
Speakers |
| Introduction to the course |
Alison Holmes, Professor in Infectious Diseases, Imperial College London, UK |
| Basics of Microbiology |
Dr. Meher Rizvi,Associate Professor, Department of Microbiology and Immunology, Sultan Qaboos University, Oman |
| Interpretation of Laboratory data |
Dr. Anilkumar, Professor, Department of Microbiology, Amrita Hospital, Kochi, Kerala |
Introduction to Pharmacology ( Part I) Kinetics
- Systematic approach in selection of antibiotic regimen
- MIC and MBC
- ABTIBIOTICS CLASSIFICATION
|
Dr. Grace Mary John, Infectious Diseases Clinical Specialist and Chief Clinical Pharmacist at Believers Church Medical College Hospital , Thiruvalla, Kerala |
Introduction to Pharmacology ( Part II) Dynamics
- Basic pharmacodynamic concepts with clinical correlation
- Drug Receptors – Brief overview · Drug Potency and Efficacy
- Dose Response Relationship
- Concentration Dependent / Time Dependent Antibiotics
- Plasma Concentration to drug effect at receptor sites
- Factors considered in drug dosing
- Factors modifying drug action
- Therapeutic drug monitoring
|
Dr. Subrajyoti Bhowmik,Associate Professor of Pharmacology at KPC Medical College, Kolkata |
Introduction to AMR( causes and spread -one health concept & burden)
- Human microbiome, definition of AMR/ABR
- Mechanisms of AMR Causes and spread of AMR
- One health concept Burden of AMR – global, India
- Healthcare, economic aspects; future scenario
|
Dr. Kiranjeet Kaur,Assistant Professor, Chitkara University, Patiala |
| How to develop and implement a one health approach to AMR |
Prof. Karin Thursky Director of the National Centre for Antimicrobial Stewardship (NCAS), Australia |
Strategies to prevent and control (policies, GAP, NAP)
- Objectives
- Interventions
- Output Policies National Policy on AMR Containment
- National programme on antimicrobial stewardship programme of infection and control (ASPIC) by ICMR
- Schedule H1 category
- Redline medical campaign
- Draft standards of antibiotic reduce in pharmaceutical industrial effluent and common effluent treatment plans developed by central pollution control board
- 3 DECLARATIONS – Jaipur, Chennai, Delhi Declarations
|
Dr. Marc Mendelson, Professor, Department of Infectious Diseases, University of Cape Town, South Africa |
| Introduction to AMSP |
Dr. Zubair Umer Mohammed, Associate Professor, Anesthesiology and Critical Care, Amrita Hospital, Kochi, Kerala |
| Principles of AMSP with examples |
Dr. Priscilla Rupali, Sr. Professor & Head of the Department of Infectious Diseases at Christian Medical College Vellore |
| Importance of multidisciplinary AMS team and how to create a team based on available resources |
Dr. Kamini Walia, Senior Scientist, Indian Council of Medical Research &DrPayal Patel,Systemwide Medical Director of Antimicrobial Stewardship at Intermountain Health, USA |
AMS strategies
- How to evaluate the inappropriateness in antimicrobial prescription and select strategies accordingly, for e.g., use of PPS
- The importance of implementing an AMS strategy based on the available resources
- Introduction to various AMS strategies in brief
- Back end strategy- prospective audit and feedback with examples
- Supplemental strategies- e.g TDM (removed— already covered in intro to pharmacology)
- How to select low hanging fruits AMS strategy in resource limited settings
|
Dr. Mohammed Hisham, Lead Clinical Pharmacist at Cleveland Clinic Abu Dhabi |
| Common clinical indication – 2 focus (session I) – URTI & LRTI , Sepsis |
Dr. Ram Subrahmaniam, Infectious Disease specialist, Apollo Hospitals Chennai, Tamil Nadu |
| Common clinical indication – 2 focus (Session II) – Intra abdominal , CNS, Bacteremia |
Carlos Palos,physician in Intensive Medicine and Internal Medicine and coordinator of the group of infection control and resistance to antimicrobials of Luz Saúde and Hospital Beatriz Ângelo, Portugal |
| Common clinical indication – 2 focus (Session III) – Skin and Soft tissue, Bone and Joint infections |
DrSubrahmaniamSwaminathan, Director of Infectious Diseases at the Gleneagles Global Hospita, Chennai, Tamil Nadu |
| Common clinical indication – 2 focus (Session IV) – Urinary tract infections, Infective Endocarditis |
DrTanusinghal,Consultant, Paediatrics and Infectious Disease, KokilabenDhirubhaiAmbani Hospital, Mumbai, Maharashtra, India |
Surgical prophylaxis
- Selection of agent (characteristics, efficacy, safety, allergies etc)
- Time of administration
- Duration
- How to do surveillance of HAI and reporting
|
DrPuneetDhar, Head, Gastrointestinal Surgery, Amrita Hospital, Faridabad, Haryana |
How to do surveillance of HAI and reporting
- Understand the purpose of surveillance for healthcare-
- Associated infections (HAIs)
- Describe key terms and case definitions used in HAI
- Surveillance
- Complete bloodstream infection (BSI) and urinary tract
- Infection (UTI), Ventilator Associated Pneumonia
- (VAP) and Surgical site Infection
- Case report forms and denominator forms
- Conduct basic analysis of HAI surveillance data
|
DrPurvaMathur, Professor, All India Institute of Medical Sciences, New Delhi |
Standard precautions
- Definition
- Hand hygiene
- PPE
- Respiratory Hygiene & Cough etiquette
- Safe injection practices
- Disinfection &sterilisation of medical equipment
- Biomedical waste management
- Handling of blood & body fluids
|
Dr Arya S Kumar, Project Scientist, Amrita Hospital, Kochi, Kerala |
Transmission based precautions, outbreak management
- Airborne precaution
- Contact
- Droplet outbreak management in hospital setting
|
DrPoornima B, Assistant Professor at the Department of Microbiology, Amrita Hosptial, Kochi, Kerala |
| Data reporting and analytics (AMSP and IPC) Types of metrices Surveillance metrices-structural, process, consumption AMR metrices- regulatory requirements |
Ms Fabia ET, Quantitative Researcher, Amrita Hospital, Kochi, Kerala |
